Evelo Biosciences Inc (EVLO) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Evelo Biosciences Inc   (NASDAQ: EVLO)


Evelo Biosciences Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Evelo Biosciences Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Evelo Biosciences Inc 's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - -78.92 % -42.81 % -41.49 % -38.66 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -19 -35 -15 52 59
Return On Investment (TTM) - - - -187.31 % -187.48 %
EVLO's Overall Ranking # # # # #
Seq. Investment Change TTM - -67.07 % -23.69 % -4.18 % -12.45 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -82 -101 -110 -115 -120

EVLO Company Profile >> Back to EVLO Roi Comparisons >> See Annual EVLO Return On Investment



Return On Investment EVLO's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Evelo Biosciences Inc's III. Quarter Investments $ -19 Millions EVLO's Balance sheet
Evelo Biosciences Inc's III. Quarter Income $ -12 Millions Quarterly EVLO's Income Statement
EVLO's Income by Division See EVLO's Income by Division


EVLO Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 52 63 61 81 151
Y / Y Investment Growth -17.02 % 3.14 % -25.08 % -46.11 % -
Net Income in Millions -115 -122 -94 -85 -57
Y / Y Net Income Growth - - - - -
Annual Return On Investment -220.05 % -194.78 % -154.01 % -105.29 % -37.8 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EVLO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EVLO's Competitors
Subscribers only: Roi for Evelo Biosciences Inc's Suppliers
Subscribers only: Return On Investment for EVLO's Customers

Other Ratios
EVLO's Roa EVLO's Inventory Turnover Ratio EVLO's Growth Rates EVLO's Dividend Statistics
EVLO's Profitability Ratios EVLO's Asset Turnover Ratio EVLO's Dividend Growth
EVLO's Roe EVLO's Valuation Ratios EVLO's Financial Strength Ratios EVLO's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-08-29T17:39:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.